NIH-funded research R21 grant

Improving metabolic treatment for neurological mitochondrial disorders

Official title: Metabolic treatment of neurological mitochondrial disorders

Funded at University of Washington · NIH-11053548 · Data updated 2026-11-12

This study is looking at how a drug called rapamycin might help improve symptoms for people with Leigh Syndrome and MELAS by blocking a specific pathway in the body, and it aims to find new ways to make treatments better for patients like you.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startApril 1, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$194,375
NIH project number5R21NS136915-02
Project IDNIH-11053548 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Leigh Syndrome or MELAS.

Less likely to help

Patients with mitochondrial disorders not related to Leigh Syndrome or MELAS may not benefit from this research.

What this research studies

This research investigates how inhibiting a specific pathway in the body, known as mTOR, can improve conditions in patients with Leigh Syndrome and MELAS, two serious neurological mitochondrial disorders. The study will explore the effects of a drug called rapamycin on metabolic changes in animal models and a small group of patients. By understanding how this drug works, researchers aim to identify new treatment strategies that could enhance patient outcomes. The research will also examine the role of certain proteins in the body that may influence the effectiveness of these treatments.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and better quality of life for patients with mitochondrial disorders.

How similar studies have gone: Previous research has shown promising results with mTOR inhibitors in similar conditions, indicating potential for success in this approach.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Bitto, Alessandro — University of Washington
  • Study coordinator: Bitto, Alessandro

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.